Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease

Scott D. Solomon, Julie Lin, Caren G. Solomon, Kathleen A. Jablonski, Madeline Murguia Rice, Michael W Steffes, Michael Domanski, Judith Hsia, Bernard J. Gersh, J. Malcolm O. Arnold, Jean Rouleau, Eugene Braunwald, Marc A. Pfeffer

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

BACKGROUND: Patients with chronic kidney disease are at increased risk for cardiovascular morbidity and mortality. We assessed the association between albuminuria and the risks for death and cardiovascular events among patients with stable coronary disease. METHODS AND RESULTS: We studied patients enrolled in the Prevention of Events with an ACE inhibitor (PEACE) trial, in which patients with chronic stable coronary disease and preserved systolic function were randomized to trandolapril or placebo and followed up for a median of 4.8 years. The urinary albumin to creatinine ratio (ACR) assessed in a core laboratory in 2977 patients at baseline and in 1339 patients at follow-up (mean 34 months) was related to estimated glomerular filtration rate and outcomes. The majority of patients (73%) had a baseline ACR within the normal range (<17 μg/mg for men and <25 μg/mg for women). Independent of the estimated glomerular filtration rate and other baseline covariates, a higher ACR, even within the normal range, was associated with increased risks for all-cause mortality (P<0.001) and cardiovascular death (P=0.01). The effect of trandolapril therapy on outcomes was not modified significantly by the level of albuminuria. Nevertheless, trandolapril therapy was associated with a significantly lower mean follow-up ACR (12.5 versus 14.6 μg/mg, P=0.0002), after adjustment for baseline ACR, time between collections, and other covariates. An increase in ACR over time was associated with increased risk of cardiovascular death (hazard ratio per log ACR 1.74, 95% CI 1.08 to 2.82). CONCLUSIONS: Albuminuria, even in low levels within the normal range, is an independent predictor of cardiovascular and all-cause mortality.

Original languageEnglish (US)
Pages (from-to)2687-2693
Number of pages7
JournalCirculation
Volume116
Issue number23
DOIs
StatePublished - Dec 1 2007

Fingerprint

Albuminuria
trandolapril
Coronary Artery Disease
Albumins
Creatinine
Reference Values
Glomerular Filtration Rate
Coronary Disease
Mortality
Chronic Renal Insufficiency
Angiotensin-Converting Enzyme Inhibitors
Placebos
Morbidity
Therapeutics

Keywords

  • Albuminuria
  • Cardiovascular diseases
  • Kidney

Cite this

Solomon, S. D., Lin, J., Solomon, C. G., Jablonski, K. A., Rice, M. M., Steffes, M. W., ... Pfeffer, M. A. (2007). Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation, 116(23), 2687-2693. https://doi.org/10.1161/CIRCULATIONAHA.107.723270

Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. / Solomon, Scott D.; Lin, Julie; Solomon, Caren G.; Jablonski, Kathleen A.; Rice, Madeline Murguia; Steffes, Michael W; Domanski, Michael; Hsia, Judith; Gersh, Bernard J.; Arnold, J. Malcolm O.; Rouleau, Jean; Braunwald, Eugene; Pfeffer, Marc A.

In: Circulation, Vol. 116, No. 23, 01.12.2007, p. 2687-2693.

Research output: Contribution to journalArticle

Solomon, SD, Lin, J, Solomon, CG, Jablonski, KA, Rice, MM, Steffes, MW, Domanski, M, Hsia, J, Gersh, BJ, Arnold, JMO, Rouleau, J, Braunwald, E & Pfeffer, MA 2007, 'Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease', Circulation, vol. 116, no. 23, pp. 2687-2693. https://doi.org/10.1161/CIRCULATIONAHA.107.723270
Solomon, Scott D. ; Lin, Julie ; Solomon, Caren G. ; Jablonski, Kathleen A. ; Rice, Madeline Murguia ; Steffes, Michael W ; Domanski, Michael ; Hsia, Judith ; Gersh, Bernard J. ; Arnold, J. Malcolm O. ; Rouleau, Jean ; Braunwald, Eugene ; Pfeffer, Marc A. / Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. In: Circulation. 2007 ; Vol. 116, No. 23. pp. 2687-2693.
@article{3db311cc26cb4eb6a65d069baabdb32c,
title = "Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease",
abstract = "BACKGROUND: Patients with chronic kidney disease are at increased risk for cardiovascular morbidity and mortality. We assessed the association between albuminuria and the risks for death and cardiovascular events among patients with stable coronary disease. METHODS AND RESULTS: We studied patients enrolled in the Prevention of Events with an ACE inhibitor (PEACE) trial, in which patients with chronic stable coronary disease and preserved systolic function were randomized to trandolapril or placebo and followed up for a median of 4.8 years. The urinary albumin to creatinine ratio (ACR) assessed in a core laboratory in 2977 patients at baseline and in 1339 patients at follow-up (mean 34 months) was related to estimated glomerular filtration rate and outcomes. The majority of patients (73{\%}) had a baseline ACR within the normal range (<17 μg/mg for men and <25 μg/mg for women). Independent of the estimated glomerular filtration rate and other baseline covariates, a higher ACR, even within the normal range, was associated with increased risks for all-cause mortality (P<0.001) and cardiovascular death (P=0.01). The effect of trandolapril therapy on outcomes was not modified significantly by the level of albuminuria. Nevertheless, trandolapril therapy was associated with a significantly lower mean follow-up ACR (12.5 versus 14.6 μg/mg, P=0.0002), after adjustment for baseline ACR, time between collections, and other covariates. An increase in ACR over time was associated with increased risk of cardiovascular death (hazard ratio per log ACR 1.74, 95{\%} CI 1.08 to 2.82). CONCLUSIONS: Albuminuria, even in low levels within the normal range, is an independent predictor of cardiovascular and all-cause mortality.",
keywords = "Albuminuria, Cardiovascular diseases, Kidney",
author = "Solomon, {Scott D.} and Julie Lin and Solomon, {Caren G.} and Jablonski, {Kathleen A.} and Rice, {Madeline Murguia} and Steffes, {Michael W} and Michael Domanski and Judith Hsia and Gersh, {Bernard J.} and Arnold, {J. Malcolm O.} and Jean Rouleau and Eugene Braunwald and Pfeffer, {Marc A.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1161/CIRCULATIONAHA.107.723270",
language = "English (US)",
volume = "116",
pages = "2687--2693",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "23",

}

TY - JOUR

T1 - Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease

AU - Solomon, Scott D.

AU - Lin, Julie

AU - Solomon, Caren G.

AU - Jablonski, Kathleen A.

AU - Rice, Madeline Murguia

AU - Steffes, Michael W

AU - Domanski, Michael

AU - Hsia, Judith

AU - Gersh, Bernard J.

AU - Arnold, J. Malcolm O.

AU - Rouleau, Jean

AU - Braunwald, Eugene

AU - Pfeffer, Marc A.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - BACKGROUND: Patients with chronic kidney disease are at increased risk for cardiovascular morbidity and mortality. We assessed the association between albuminuria and the risks for death and cardiovascular events among patients with stable coronary disease. METHODS AND RESULTS: We studied patients enrolled in the Prevention of Events with an ACE inhibitor (PEACE) trial, in which patients with chronic stable coronary disease and preserved systolic function were randomized to trandolapril or placebo and followed up for a median of 4.8 years. The urinary albumin to creatinine ratio (ACR) assessed in a core laboratory in 2977 patients at baseline and in 1339 patients at follow-up (mean 34 months) was related to estimated glomerular filtration rate and outcomes. The majority of patients (73%) had a baseline ACR within the normal range (<17 μg/mg for men and <25 μg/mg for women). Independent of the estimated glomerular filtration rate and other baseline covariates, a higher ACR, even within the normal range, was associated with increased risks for all-cause mortality (P<0.001) and cardiovascular death (P=0.01). The effect of trandolapril therapy on outcomes was not modified significantly by the level of albuminuria. Nevertheless, trandolapril therapy was associated with a significantly lower mean follow-up ACR (12.5 versus 14.6 μg/mg, P=0.0002), after adjustment for baseline ACR, time between collections, and other covariates. An increase in ACR over time was associated with increased risk of cardiovascular death (hazard ratio per log ACR 1.74, 95% CI 1.08 to 2.82). CONCLUSIONS: Albuminuria, even in low levels within the normal range, is an independent predictor of cardiovascular and all-cause mortality.

AB - BACKGROUND: Patients with chronic kidney disease are at increased risk for cardiovascular morbidity and mortality. We assessed the association between albuminuria and the risks for death and cardiovascular events among patients with stable coronary disease. METHODS AND RESULTS: We studied patients enrolled in the Prevention of Events with an ACE inhibitor (PEACE) trial, in which patients with chronic stable coronary disease and preserved systolic function were randomized to trandolapril or placebo and followed up for a median of 4.8 years. The urinary albumin to creatinine ratio (ACR) assessed in a core laboratory in 2977 patients at baseline and in 1339 patients at follow-up (mean 34 months) was related to estimated glomerular filtration rate and outcomes. The majority of patients (73%) had a baseline ACR within the normal range (<17 μg/mg for men and <25 μg/mg for women). Independent of the estimated glomerular filtration rate and other baseline covariates, a higher ACR, even within the normal range, was associated with increased risks for all-cause mortality (P<0.001) and cardiovascular death (P=0.01). The effect of trandolapril therapy on outcomes was not modified significantly by the level of albuminuria. Nevertheless, trandolapril therapy was associated with a significantly lower mean follow-up ACR (12.5 versus 14.6 μg/mg, P=0.0002), after adjustment for baseline ACR, time between collections, and other covariates. An increase in ACR over time was associated with increased risk of cardiovascular death (hazard ratio per log ACR 1.74, 95% CI 1.08 to 2.82). CONCLUSIONS: Albuminuria, even in low levels within the normal range, is an independent predictor of cardiovascular and all-cause mortality.

KW - Albuminuria

KW - Cardiovascular diseases

KW - Kidney

UR - http://www.scopus.com/inward/record.url?scp=37349052017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349052017&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.107.723270

DO - 10.1161/CIRCULATIONAHA.107.723270

M3 - Article

VL - 116

SP - 2687

EP - 2693

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 23

ER -